Time to treatment does not influence overall survival in newly diagnosed mantle-cell lymphoma. [electronic resource]
Producer: 20100106Description: e189-90; author reply e191 p. digitalISSN:- 1527-7755
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Cyclophosphamide -- administration & dosage
- Doxorubicin -- administration & dosage
- Humans
- Lymphoma, Mantle-Cell -- drug therapy
- Prednisolone -- administration & dosage
- Prognosis
- Survival Analysis
- Time Factors
- Treatment Outcome
- Vincristine -- administration & dosage
No physical items for this record
Publication Type: Comment; Letter
There are no comments on this title.
Log in to your account to post a comment.